Recent Posts

Watch These Eli Lilly Price Levels as Stock Slumps on Tepid Sales Outlook

Well-spring: TradingView.com Key Takeaways Eli Lilly shares could remain under the microscope on Wednesday after falling sharply Tuesday as the pharmaceutical ogre lowered its 2024 full-year revenue forecast. This tepid outlook adds to concerns about moderating claim for its flagship weigh-loss drugs. The stock staged a decisive breakdown below the …

Read More »